Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

New, less damaging treatments are giving some patients the choice to try to preserve their ability to have children after ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the ...

Researchers from the Tata Memorial Centre (TMC), Mumbai, and the National Institute of Biomedical Genomics (NIBMG) in West Bengal on Wednesday claimed to have found key genomic factors that contribute ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

The 55-year-old, who was diagnosed with breast cancer in 2015, opened up about it all on Monday's episode of the ITV show.

Findings showed datopotamab deruxtecan reduced the risk of disease progression or death by 37% compared with chemotherapy.